A new study led by researchers from Huazhong University of Science and Technology in Wuhan, China provides direct evidence supporting the personalized supplementation of synbiotics for immunomodulation.
A new study led by researchers from Huazhong University of Science and Technology in Wuhan, China provides direct evidence supporting the personalized supplementation of synbiotics for immunomodulation.
MyJournals.org - Science - IJMS, Vol. 24, Pages 10979: Immunomodulation Therapies for Atherosclerosis: The Past, the Present, and the Future (International Journal of Molecular Sciences)
NEW YORK, May 23, 2023 Tiziana Life Sciences Ltd. , a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced that they. | May 23, 2023